News
16S Microbiome NGS Assay
Check out our improved 16S Microbiome NGS Assay
We now offer an improved version of our NGS Assay with a more easier and even faster library preparation protocol bundled with data analysis for accurate species level-classification.
Improvements:
- Fast and optimized 2-step protocol minimizes set-up time
- More balanced heterogeneity spacers to enhance library complexity for improved sequencing quality
- Elimination of PhiX spike-in results in lower reagent expenses, more samples per sequencing run and therefore lower costs per sample
For more detailed information follow this link.
Season's Greetings
Thank you!
This year is coming to an end and thus we want to use this opportunity to thank our business partners, customers and distribution partners for your trust in us.
We wish you and your family happy holidays and a prosperous New Year!
ViennaLab Team
MEDICA Trade Fair 2022
Visit us at MEDICA 2022
The live event will be held from November 14 - 17, 2022 and we will be on site.
We are exhibiting together with our mother company, BioVendor, in Hall 3 A92.
We are really looking forward to meet with you again in person!
MedPhab
ViennaLab Diagnostics is part of the MedPhab consortium funded by a Horizon 2020 research grant.
MedPhab serves as Europe’s first Pilot Line dedicated to manufacturing, testing, validation and up-scaling of new photonics technologies for medical diagnostics. The purpose of MedPhab pilot production line is to accelerate the commercialisation of diagnostic devices and instruments for treatment based on photonics, and to reduce the R&D costs. pdf Read more .
Medphab is launching an Open Call for external companies developing medical products. pdf Read more .
12th EMMD 2022
12th European Meeting on Molecular Diagnostics 2022
The live event will be held from October 12 - 14, 2022.
ViennaLab is represented by our local distribution partner, Goffin Molecular Technologies. You find us at booth 26.
We are looking forward to your visit!
NGS Product Launch
Explore the full power of NGS
At the beginning of July we launched our NGS Assays which provide the next level of variant analysis by Next Generation Sequencing (NGS).
We provide our customers an all-in-one solution, comprising library preparation, bioinformatic analysis via Genovesa and genetic variant report generation.
Interested to learn more about the features? Contact
ESHG 2022 Conference
European Society of Human Genetics 2022 Conference is taking place as usual - LIVE!
The live event will be held from June 11 - 14, 2022.
ViennaLab is exhibiting together with our mother company, BioVendor, at booth X5-234.
We are looking forward to your visit!
Frühjahrstagung 2022
Österreichische Gesellschaft für Klinische Pathologie und Molekularpathologie / Österreichische Abteilung der Internationalen Akademie für Pathologie (ÖGPath/IAP Austria)
Die Frühjahrstagung findet vom 11. bis 12. März 2022 in persona statt.
TechGate Vienna, Donau City Wien
ViennaLab wird abermals vom österreichischen Vertriebspartner HVD Life Science Vertriebs GmbH bei der Industrieausstellung vertreten.
Wir freuen uns auf Ihren Besuch auf unserem Messestand!
Medlab ME 2022
Medlab Middle East 2022 is taking place as usual - Back to business in person!
The live event will be held from January 24 - 27, 2022.
ViennaLab is exhibiting together with our mother company, BioVendor, at booth Z5.D30 and in parallel with HVD VertriebsGmbH at booth Z5.D20.
We are looking forward to your visit!
Press Release - BioVendor Group
BioVendor is changing its face!
Introducing the new BioVendor Group identity!
BioVendor Group is growing. Since its foundation in 1992, the original small company has been transformed into a multinational group supported by its own R&D division. It includes the established brands BioVendor R&D, TestLine, DiaSource, ViennaLab and Oxford BioSystems.
Please click here to read more about the pdf press release .
SARS-CoV-2 PCR assay
ViennaLab successfully developed a one step real-time reverse transcription PCR (RT-PCR) assay for the highly sensitive detection of SARS-CoV-2.
Assay Features:
- virus gene targets: N and RdRP/ORF1ab
- human ACTB gene (endogenous control)
- LoD: 10 copies per reaction
- CE/IVD
Please click here to download the pdf IFU and appropriate pdf product flyer .